Your browser doesn't support javascript.
loading
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells.
Gu, Li; Zhu, Yahui; Lee, Maiya; Nguyen, Albert; Ryujin, Nicolas T; Huang, Jian Yu; Pandit, Shusil K; Chamseddine, Shadi; Xiao, Lianchun; Mohamed, Yehia I; Kaseb, Ahmed O; Karin, Michael; Shalapour, Shabnam.
Afiliación
  • Gu L; Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology and Pathology, School of Medicine, University of California San Diego, San Diego, CA 92093.
  • Zhu Y; Department of Center of Smart Laboratory and Molecular Medicine, School of Medicine, Chongqing University, Chongqing 400044, China.
  • Lee M; Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology and Pathology, School of Medicine, University of California San Diego, San Diego, CA 92093.
  • Nguyen A; Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology and Pathology, School of Medicine, University of California San Diego, San Diego, CA 92093.
  • Ryujin NT; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Huang JY; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Pandit SK; Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology and Pathology, School of Medicine, University of California San Diego, San Diego, CA 92093.
  • Chamseddine S; Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology and Pathology, School of Medicine, University of California San Diego, San Diego, CA 92093.
  • Xiao L; Gastrointestinal Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Mohamed YI; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Kaseb AO; Gastrointestinal Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Karin M; Gastrointestinal Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Shalapour S; Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology and Pathology, School of Medicine, University of California San Diego, San Diego, CA 92093.
Proc Natl Acad Sci U S A ; 120(19): e2300706120, 2023 05 09.
Article en En | MEDLINE | ID: mdl-37126700
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Enfermedad del Hígado Graso no Alcohólico / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Enfermedad del Hígado Graso no Alcohólico / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article